Predicting Success of Decannulation Using Wearable-derived Physiology
NCT ID: NCT07198425
Last Updated: 2026-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
120 participants
OBSERVATIONAL
2026-01-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Decannulation criteria: If the patient can tolerate wearing the speaking valve continuously for 4 hours (gradually increasing the duration: 30 minutes, 1 hour, 2 hours, 4 hours), and if PEF \> 100 liters/min, planned removal of the tracheostomy tube can be considered.
Based on decannulation outcomes, patients were categorized into the successful decannulation group and the failed decannulation group.
Successful decannulation group: Patients who successfully completed the decannulation process and had their tubes removed, with no reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours after decannulation.
Failed decannulation group: Patients who did not pass the decannulation process, and the multidisciplinary team advised against removal of the tracheostomy tube; or patients who passed the decannulation process and had the tracheostomy tube removed but required reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours due to medical conditions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SV With TTPEE Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients
NCT07107243
Ventilator Associated Pneumonia and Late Complications of Percutaneous Tracheostomy
NCT00184925
A Prospective, Randomized Trial of Early Versus Late Tracheostomy in Trauma Patients With Severe Brain Injury
NCT00292097
Continuous Control of Polyurethane Tracheal-cuff Pressure: Efficiency of a Pneumatic Device
NCT01351259
Assessment of Cough Strength in Patients With Tracheostomies
NCT02566512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Successful decannulation group
Patients who successfully completed the decannulation process and had their tubes removed, with no reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours after decannulbation.
Successful decannulation group
Patients who did not pass the decannulation process, and the multidisciplinary team advised against removal of the tracheostomy tube; or patients who passed the decannulation process and had the tracheostomy tube removed but required reinsertion of the tracheostomy tube or endotracheal intubation within 48 hours due to medical conditions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tracheotomy completed, ≥48 hours since cannula placement (postoperative early edema has stabilized).
* Patient or legal representative has provided informed consent.
* Known contraindications for tracheotomy decannulation.
Exclusion Criteria
* Severe consciousness disorder/delirium (RASS ≤ -3 or ≥ +2), extreme anxiety/inability to cooperate.
* Total laryngectomy or laryngo-tracheal separation.
* Oral endotracheal intubation.
* Age \<18 years.
* Malignant tumor with an expected survival time ≤ 6 months.
* Patients or legal representatives unable to obtain informed consent.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Rehabilitation Hospital
OTHER
Chinese PLA General Hospital
OTHER
Bin Zhang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bin Zhang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hongying Jiang
Role: STUDY_CHAIR
Beijing Rehabilitation Hospital of Capital Medical University, Beijing, China
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-bjkfyy-ppfs-ud
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.